Analyst firms · Morgan Stanley · MET

Morgan Stanley MET price target and rating history

MetLife Inc. (MET) · Finance

Morgan Stanley rates MetLife Inc. (MET) Overweight with a $79 price target, as of its latest action on Feb 22, 2022. It has published 5 rating actions on MET since July 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a MET price target in the last 12 months, the median target is $101.

Current rating
Overweight
Price target
$79
Median target, all firms
$101
Actions on MET
5

Morgan Stanley price target on MET

$79$76$7320222023202420252026
Morgan Stanley price target on MET, each point a stated target, July 2021 to February 2022.

Every Morgan Stanley rating on MET

How other firms rate MET

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerOverweight$110Sep 22, 2026
Evercore ISIIn-line$97Jan 6, 2026
MizuhoOutperform$101Dec 16, 2025

Questions about Morgan Stanley and MET

What is Morgan Stanley's price target for MET?
Morgan Stanley's latest stated price target for MetLife Inc. (MET) is $79, from its action on Feb 22, 2022.
What is Morgan Stanley's rating on MET?
Morgan Stanley rates MET Overweight, a bullish rating, as of Feb 22, 2022.
When did Morgan Stanley last change its view on MET?
On Feb 22, 2022, Morgan Stanley raises its price target to $79 from $76, keeps Overweight.
How does Morgan Stanley's MET target compare with other analysts?
Across 3 firms with a MET price target in the last 12 months, the median target is $101.

More MET rating histories

All Morgan Stanley ratingsMET news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.